BYON4413
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BYON4413, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms. [Phase 1]